2010 Seventh International SIO Conference

New York

Clinical Research

Pancreatic Proteolytic Enzyme Therapy Fails To Increase Survival or Quality of Life Compared to Conventional Gemcitabine Cytotoxic Therapy.

Wednesday, 09 September 2009 11:45 Clinical Studies

....those who chose gemcitabine-based chemotherapy survived morethan three times as long (14.0 v 4.3 months) and had betterquality of life than those who chose proteolytic enzyme treatment.

Add Comment (0)

Methodology for Clinical Trials in Integrative Oncology by Andrew Vickers PhD.

Friday, 04 September 2009 08:33 Clinical Studies

E-mail | Print | PDF

Add Comment (0)

A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.

Tuesday, 11 August 2009 13:45 Clinical Studies

E-mail | Print | PDF

Cancer patients should be made aware of the fact that botanical agents produce more complex effects than assumed, and may depress as well as enhance immune function.

Add Comment (0)

Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients.

Tuesday, 11 August 2009 13:54 Clinical Studies

E-mail | Print | PDF

Jinfukang did not alter the pharmacokinetics of docetaxel nor appear to affect survival in this study.

Add Comment (0)

Evaluation of widely consumed botanicals as immunological adjuvants

Tuesday, 11 August 2009 13:50 Clinical Studies

E-mail | Print | PDF

Some, but not all, botanicals purported to be immune stimulants had adjuvant activity in our model. PSK and Astragalus were surprisingly active and are being further fractionated to identify the most active adjuvant components.

Add Comment (0)

More Articles...